CHARLES GLASS: Open Payments
NPI 1003219304 · LEAVENWORTH, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,275 in 214 payments from 16 companies in 2025. Trend: 2023 $2,112 · 2024 $3,162 · 2025 $3,275
Food & beverage: $3,175Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 33 | $634 |
| ABBVIE INC. | 33 | $391 |
| Novartis Pharmaceuticals Corporation | 22 | $384 |
| UCB, Inc. | 25 | $327 |
| Lilly USA, LLC | 20 | $290 |
| Amgen Inc. | 18 | $259 |
| E.R. Squibb & Sons, L.L.C. | 22 | $230 |
| Galderma Laboratories, L.P. | 14 | $222 |
| GENZYME CORPORATION | 6 | $141 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $136 |
Products named: TREMFYA, COSENTYX, Bimzelx, OTEZLA, TALTZ, Sotyktu, RINVOQ, SKYRIZI.
Industry payments across KS — which companies pay providers there.
